Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    CBRNE

    DTRA Contracts for Botulinum Neurotoxin Countermeasures Research

    By Global Biodefense StaffFebruary 20, 2014
    Share
    Facebook LinkedIn Reddit Email

    The Defense Threat Reduction Agency (DTRA) this week announced intentions to award three contracts in support of “Medical Countermeasures for Botulinum Neurotoxin Intoxication Focused on Therapeutics and Neuroregenerative Medicines”.

    DTRA has established a multicenter program in which directed research projects are submitted, evaluated and selected to sponsor a network of collaboration amongst researchers. Under the multicenter collaboration, the following three proposals were selected for funding, to be administered in coordination with US Army Medical Research Institute of Chemical Defense (USAMRICD) collaborators:

    Montclair State University: MSU will contribute to the botulinum drug discovery effort by synthesizing small molecule drug candidates for treatment of botulinum toxin exposure and optimizing their pharmaceutical properties. First year of research cost is estimated at $428,737. Total five year proposal cost is $2,515,123 

    UMass Dartmouth: UMD will support the efforts at the USAMRICD by performing high throughput screening of natural product and small molecule libraries. First year of research cost is estimated at $275,044. Total five year proposal cost is $2,876,104 

    Ossianix University: Ossianix will provide an alternative to traditional inhibitors by developing small single chain shark antibodies (VNRS) as potential inhibitors of LC catalytic activity. Ossianix first year of research cost is estimated at $214,608. Total five year proposal cost is $1 Million. 

    This consortium type research is under the Memorandum of Agreement (MOA) between DTRA and USAMRICD.  

    Source: FBO.gov

    Awards Botulinum Neurotoxin Defense Threat Reduction Agency USAMRICD
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleMRSA Superbug Protein Structure Solved
    Next Article RFI – Chemical and Biological Agent Blast Environments

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Terrorism and the Pandemic: Weaponizing a Public Health Crisis

    September 20, 2023

    SOREX Brings Top CBRNE Units to Dugway Proving Ground

    September 20, 2023

    Biomarkers for Detection of Exposure to Nitrogen Mustards

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.